Reference health

PharmGKB: A worldwide resource for pharmacogenomic information

https://doi.org/10.1002/wsbm.1417
CiteStamped reference-health badge
29/29 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

11 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 29 checked references that resolve
resolves10.1038/425760a
With your genes? Take one of these, three times a day
resolves10.1097/FPC.0000000000000040
PharmGKB summary
resolves10.1016/j.humimm.2011.12.002
Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus–positive patients from southern Alberta
resolves10.2174/1389200215666140130124910
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
resolves10.1146/annurev-pharmtox-010814-124835
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
resolves10.31887/DCNS.2014.16.4/egershon
Ethical and public policy challenges for pharmacogenomics
resolves10.1001/jama.2013.1927
Genomic Medicine
resolves10.1038/nature11147
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
resolves10.1371/journal.pcbi.1002817
Chapter 7: Pharmacogenomics
resolves10.1038/sj.tpj.6500035
Integrating genotype and phenotype information: an overview of the PharmGKB project
resolves10.1002/cpt.630
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
resolves10.1038/clpt.2014.38
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 Update
resolves10.1126/science.aab4082
Somatic mutation in cancer and normal cells
resolves10.2217/bmm.11.94
From Pharmacogenomic Knowledge Acquisition to Clinical Applications: The PharmGKB as a Clinical Pharmacogenomic Biomarker Resource
resolves10.1097/QAD.0b013e328355fe8f
Abacavir induces loading of novel self-peptides into HLA-B*57
resolves10.1073/pnas.1207934109
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
resolves10.1038/nature15817
Pharmacogenomics in the clinic
resolves10.1038/clpt.2013.4
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
resolves10.1038/clpt.2010.320
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
resolves10.1038/clpt.2010.279
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
resolves10.1089/thy.2010.1642
The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology
resolves10.1097/GIM.0b013e318238b38c
Personalizing medicine with clinical pharmacogenetics
resolves10.1038/clpt.2011.34
Pharmacogenetics: From Bench to Byte— An Update of Guidelines
resolves10.1038/sj.clpt.6100507
Pharmacogenetics: From Bench to Byte
resolves10.2217/pgs.10.15
Pharmacogenomics and Bioinformatics: Pharmgkb
resolves10.1097/FPC.0b013e3283352860
Very important pharmacogene summary: thiopurine S-methyltransferase
resolves10.1146/annurev.genom.6.080604.162315
Pharmacogenetics and Pharmacogenomics: Development, Science, and Translation
resolves10.1097/FPC.0b013e328334338f
Thiopurine pathway
The 11 references without a DOI — listed, not checked
no DOI — not checkedAstraZeneca Pharmaceuticals LP. (2015). IRESSA—gefitinib tablet coated [package insert]. AstraZeneca Pharmaceuticals LP Delaware.
no DOI — not checkedMedical genetics summaries
no DOI — not checkedGenentech Inc. (2015). HERCEPTIN (trastuzumab) for injection for intravenous use. Genentech Inc California.
no DOI — not checkedGenentech USA Inc. (2016). ZELBORAF (vemurafenib) [pacakge insert]. Genentech USA Inc. California.
no DOI — not checkedAn introduction to genetic analysis
no DOI — not checkedClinical Pharmacology and Therapeutics 2017 PharmCAT: A Pharmacogenomics Clinical Annotation Tool
no DOI — not checkedTPMT alleles
no DOI — not checkedHolland‐Frei cancer medicine
no DOI — not checkedThe Precision Medicine Initiative. (2015). Retrieved fromhttps://obamawhitehouse.archives.gov/node/333101
no DOI — not checkedViiV Healthcare Company. (2015). ZIAGEN—abacavir sulfate tablet film‐coated [package insert]. ViiV Healthcare Company Canada.
no DOI — not checkedViiV Healthcare ULC. (2015) ZIAGEN—abacavir tablets 300 mg (as abacavir sulfate). Abacavir oral solution 20 mg/ml (as abacavir sulfate) [package insert]. ViiV Healthcare ULC Quebec.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1002/wsbm.1417"><img src="https://citestamp.com/citestamped/10.1002/wsbm.1417/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1002/wsbm.1417/badge.svg)](https://citestamp.com/citestamped/10.1002/wsbm.1417)